Ionis Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: IONS
Share price (3/17/26): $72.33
Market cap (3/17/26): $11.9 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Automatic shelf registration

Ownership Filter

Hougen Elizabeth L

Hougen Elizabeth L

O'NEIL Patrick R.

News Filter

Announces Changes to Board of Directors – Lynne Parshall and Joseph Wender to Retire at End of Term in June 2026 and Peter Reikes to Join Ionis Board –

Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Progress on Key Programs

Well-Positioned for Continued Momentum and Substantial Value Creation in 2026 With Two New Independent Launches and Several Pivotal Data Readouts

Partner GSK Announces Positive Topline Results From B-Well 1 and B-Well 2 Phase 3 Studies for Bepirovirsen, a Potential First-In-Class Medicine for Chronic Hepatitis B

Announces Proposed Convertible Offering to Refinance 2026 Convertible Notes

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC